Befloxatone

Names

[ Name ]:
Befloxatone

[Synonym ]:
UNII-4H75PAD8M3
(R)-5-(methoxymethyl)-3-(p[(R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl)-2-oxazolidinone
BEFLOXATONE
(R)-5-(methoxymethyl)-3-(4-((R)-4,4,4-trifluoro-3-hydroxybutoxy)phenyl)-oxazolidin-2-one
Befloxatone (INN)

Biological Activity

[Description]:

Befloxatone (MD-370503) is an orally active, selective and reversible inhibitor of Monoamine Oxidase A (MAO-A) (IC50=4 nM). Befloxatone increases the tissue level of monoamine, striatal dopamine and cortical norepinephrine. Befloxatone has antidepressant potential[1].

[Related Catalog]:

Signaling Pathways >> Neuronal Signaling >> Monoamine Oxidase

Research Areas >> Neurological Disease

[Target]

MAO-A:4 nM (IC50)

MAO-B:300 nM (IC50)

[In Vitro]

Befloxatone (100 nM; 0-100 min) 可逆抑制大鼠脑匀浆中的 MAO-A 活性，60 min 后不再发挥抑制作用[1]。

[In Vivo]

Befloxatone (0.75 mg/kg; i.p.; single dose) 在大鼠中增加单胺的组织水平，并降低其脱氨基代谢物的水平[1]。 Befloxatone (1 mg/kg; i.p.; single dose) 可诱导大鼠细胞外纹状体多巴胺和皮质去甲肾上腺素水平升高，但不诱导皮质 5-羟色胺水平升高[1]。 Befloxatone (0.03-0.3 mg/kg; p.o.; single dose) 在大鼠中有效抑制血清素能神经元的放电速率，部分降低去甲肾上腺素能神经元的发射，对多巴胺能神经元的激发没有影响[1]。 Befloxatone (1.5 mg/kg; p.o.; single dose) 在大鼠中不会增强中心活性剂量口服酪胺的升压作用，具有广泛的安全性[1]。

[References]

[1]. Curet O, et al. Preclinical profile of befloxatone, a new reversible MAO-A inhibitor. J Affect Disord. 1998 Dec;51(3):287-303.

Chemical & Physical Properties

[ Density]:
1.326g/cm3

[ Boiling Point ]:
447.3ºC at 760mmHg

[ Molecular Formula ]:
C₁₅H₁₈F₃NO₅

[ Molecular Weight ]:
349.30200

[ Flash Point ]:
224.3ºC

[ Exact Mass ]:
349.11400

[ PSA ]:
68.23000

[ LogP ]:
2.41530

[ Vapour Pressure ]:
8.73E-09mmHg at 25°C

[ Index of Refraction ]:
1.498

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.